메뉴 건너뛰기




Volumn 9, Issue 8, 2013, Pages 474-481

New treatments for mitochondrial disease - No time to drop our standards

(17)  Pfeffer, Gerald a   Horvath, Rita l   Klopstock, Thomas b   Mootha, Vamsi K c   Suomalainen, Anu d   Koene, Saskia e   Hirano, Michio f   Zeviani, Massimo g   Bindoff, Laurence A h   Yu Wai Man, Patrick a   Hanna, Michael i   Carelli, Valerio j   Mcfarland, Robert a   Majamaa, Kari k   Turnbull, Douglas M a   Smeitink, Jan e   Chinnery, Patrick F a  


Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; BIOLOGICAL MARKER; CARNITINE; CREATINE; CYSTEINE; DICHLOROACETIC ACID; DIMETHYLGLYCINE; IDEBENONE; NICOTINIC ACID; RIBOFLAVIN; SUCCINIC ACID; THIAMINE; THIOCTIC ACID; UBIDECARENONE; VATIQUINONE; VITAMIN K GROUP;

EID: 84881375649     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2013.129     Document Type: Review
Times cited : (154)

References (77)
  • 1
    • 84868157585 scopus 로고    scopus 로고
    • Unintended effects of orphan product designation for rare neurological diseases
    • Murphy, S. M., Puwanant, A. & Griggs, R. C. Unintended effects of orphan product designation for rare neurological diseases. Ann. Neurol. 72, 481-490 (2012
    • (2012) Ann. Neurol , vol.72 , pp. 481-490
    • Murphy, S.M.1    Puwanant, A.2    Griggs, R.C.3
  • 2
    • 84864127384 scopus 로고    scopus 로고
    • Ethical considerations in orphan drug approval and use
    • Kesselheim, A. S. Ethical considerations in orphan drug approval and use. Clin. Pharmacol. Ther. 92, 153-155 (2012
    • (2012) Clin. Pharmacol. Ther , vol.92 , pp. 153-155
    • Kesselheim, A.S.1
  • 4
    • 0028850504 scopus 로고
    • Primary and secondary carnitine deficiency syndromes
    • Pons, R. & De Vivo, D. C. Primary and secondary carnitine deficiency syndromes. J. Child. Neurol. 10 (Suppl. 2), S8-S24 (1995
    • (1995) J. Child. Neurol , vol.10 , Issue.SUPPL. 2
    • Pons, R.1    De Vivo, D.C.2
  • 5
    • 0030020607 scopus 로고    scopus 로고
    • Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome
    • Majamaa, K., Rusanen, H., Remes, A. M., Pyhtinen, J. & Hassinen, I. E. Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome. Life Sci. 58, 691-699 (1996
    • (1996) Life Sci , vol.58 , pp. 691-699
    • Majamaa, K.1    Rusanen, H.2    Remes, A.M.3    Pyhtinen, J.4    Hassinen, I.E.5
  • 6
    • 0019596345 scopus 로고
    • Correction of increased plasma pyruvate and plasma lactate levels using large doses of thiamine in patients with Kearns-Sayre syndrome
    • Lou, H. C. Correction of increased plasma pyruvate and plasma lactate levels using large doses of thiamine in patients with Kearns-Sayre syndrome. Arch. Neurol. 38, 469 (1981
    • (1981) Arch. Neurol , vol.38 , pp. 469
    • Lou, H.C.1
  • 7
    • 0024452528 scopus 로고
    • The pharmacology of dichloroacetate
    • Stacpoole, P. W. The pharmacology of dichloroacetate. Metabolism 38, 1124-1144 (1989
    • (1989) Metabolism , vol.38 , pp. 1124-1144
    • Stacpoole, P.W.1
  • 9
    • 0029086146 scopus 로고
    • Function of coenzyme Q in the cell: Some biochemical and physiological properties
    • Rauchová, H., Drahota, Z. & Lenaz, G. Function of coenzyme Q in the cell: Some biochemical and physiological properties. Physiol. Res. 44, 209-216 (1995
    • (1995) Physiol. Res , vol.44 , pp. 209-216
    • Rauchová, H.1    Drahota, Z.2    Lenaz, G.3
  • 10
    • 80052211991 scopus 로고    scopus 로고
    • Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues
    • Orsucci, D., Mancuso, M., Lenco, E. C., LoGerfo, A. & Siciliano, G. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. Curr. Med. Chem. 18, 4053-4064 (2011
    • (2011) Curr. Med. Chem , vol.18 , pp. 4053-4064
    • Orsucci, D.1    Mancuso, M.2    Lenco, E.C.3    LoGerfo, A.4    Siciliano, G.5
  • 11
    • 79957829839 scopus 로고    scopus 로고
    • Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging
    • Shrader, W. D. et al. α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging. Bioorg. Med. Chem. Lett. 21, 3693-3698 (2011
    • (2011) Bioorg. Med. Chem. Lett , vol.21 , pp. 3693-3698
    • Shrader, W.D.1
  • 12
    • 0024317560 scopus 로고
    • Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndromes associated with a mitochondrial DNA deletion: A slip-replication model and metabolic therapy
    • Shoffner, J. M. et al. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndromes associated with a mitochondrial DNA deletion: A slip-replication model and metabolic therapy. Proc. Natl Acad. Sci. USA 86, 7952-7956 (1989
    • (1989) Proc. Natl Acad. Sci. USA , vol.86 , pp. 7952-7956
    • Shoffner, J.M.1
  • 13
    • 0021449807 scopus 로고
    • 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle
    • Eleff, S. et al. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc. Natl Acad. Sci. USA 81, 3529-3533 (1984
    • (1984) Proc. Natl Acad. Sci. USA , vol.81 , pp. 3529-3533
    • Eleff, S.1
  • 14
    • 77954455562 scopus 로고    scopus 로고
    • Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation
    • Mancuso, M. et al. Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J. Neurol. 257, 774-781 (2010
    • (2010) J. Neurol , vol.257 , pp. 774-781
    • Mancuso, M.1
  • 15
    • 0037241026 scopus 로고    scopus 로고
    • The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: A double-blind randomized crossover clinical trial
    • Liet, J. M. et al. The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: A double-blind randomized crossover clinical trial. J. Pediatr. 142, 62-66 (2003
    • (2003) J. Pediatr , vol.142 , pp. 62-66
    • Liet, J.M.1
  • 16
    • 80052800016 scopus 로고    scopus 로고
    • The creatine kinase system and pleiotropic effects of creatine
    • Wallimann, T., Tokarska-Schlattner, M. & Schlattner, U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40, 1271-1296 (2011
    • (2011) Amino Acids , vol.40 , pp. 1271-1296
    • Wallimann, T.1    Tokarska-Schlattner, M.2    Schlattner, U.3
  • 17
    • 24144448004 scopus 로고    scopus 로고
    • Exercise training in mitochondrial myopathy: A randomized controlled trial
    • Cejudo, P. et al. Exercise training in mitochondrial myopathy: A randomized controlled trial. Muscle Nerve 32, 342-350 (2005
    • (2005) Muscle Nerve , vol.32 , pp. 342-350
    • Cejudo, P.1
  • 18
    • 13844321746 scopus 로고    scopus 로고
    • L-Arginine improves the symptoms of strokelike episodes in MELAS
    • Koga, Y. et al. L-Arginine improves the symptoms of strokelike episodes in MELAS. Neurology 64, 710-712 (2005
    • (2005) Neurology , vol.64 , pp. 710-712
    • Koga, Y.1
  • 19
    • 84861161948 scopus 로고    scopus 로고
    • Steroid responsive A3243G mutation MELAS: Clinical and radiographic evidence for regional hyperperfusion leading to neuronal loss
    • Walcott, B. P. et al. Steroid responsive A3243G mutation MELAS: Clinical and radiographic evidence for regional hyperperfusion leading to neuronal loss. Neurologist 18, 159-170 (2012
    • (2012) Neurologist , vol.18 , pp. 159-170
    • Walcott, B.P.1
  • 20
    • 77956393641 scopus 로고    scopus 로고
    • Mitochondrial myopathies: Developments in treatment
    • Hassani, A., Horvath, R. & Chinnery, P. F. Mitochondrial myopathies: Developments in treatment. Curr. Opin. Neurol. 23, 459-465 (2010
    • (2010) Curr. Opin. Neurol , vol.23 , pp. 459-465
    • Hassani, A.1    Horvath, R.2    Chinnery, P.F.3
  • 21
    • 0025673969 scopus 로고
    • Ubidecarenone in the treatment of mitochondrial myopathies: A multi-center double-blind trial
    • Bresolin, N. et al. Ubidecarenone in the treatment of mitochondrial myopathies: A multi-center double-blind trial. J. Neurol. Sci. 100, 70-78 (1990
    • (1990) J. Neurol. Sci , vol.100 , pp. 70-78
    • Bresolin, N.1
  • 22
    • 76349123010 scopus 로고    scopus 로고
    • Treatment of mitochondrial electron transport chain disorders: A review of clinical trials over the past decade
    • Kerr, D. S. Treatment of mitochondrial electron transport chain disorders: A review of clinical trials over the past decade. Mol. Genet. Metab. 99, 246-255 (2010
    • (2010) Mol. Genet. Metab , vol.99 , pp. 246-255
    • Kerr, D.S.1
  • 23
    • 84881372228 scopus 로고    scopus 로고
    • online
    • CureMito [online], http://curemito.org/ (2012
    • (2012) Cure Mito
  • 25
    • 4744357401 scopus 로고    scopus 로고
    • Chronic treatment of mitochondrial disease patients with dichloroacetate
    • Barshop, B. A. et al. Chronic treatment of mitochondrial disease patients with dichloroacetate. Mol. Genet. Metab. 83, 138-149 (2004
    • (2004) Mol. Genet. Metab , vol.83 , pp. 138-149
    • Barshop, B.A.1
  • 26
    • 84869874364 scopus 로고    scopus 로고
    • Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI 743 in patients with mitochondrial disease
    • Blankenberg, F. G. et al. Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI 743 in patients with mitochondrial disease. Mol. Genet. Metab. 107, 690-699 (2012
    • (2012) Mol. Genet. Metab , vol.107 , pp. 690-699
    • Blankenberg, F.G.1
  • 27
    • 0027459172 scopus 로고
    • Plasma carnitine insufficiency and effectiveness of l carnitine therapy in patients with mitochondrial myopathy
    • Campos, Y. et al. Plasma carnitine insufficiency and effectiveness of l carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 16, 150-153 (1993
    • (1993) Muscle Nerve , vol.16 , pp. 150-153
    • Campos, Y.1
  • 28
    • 0030612535 scopus 로고    scopus 로고
    • Coenzyme Q10 treatment in mitochondrial encephalomyopathies Short-term double-blind, crossover study
    • Chen, R. S., Huang, C. C. & Chu, N. S. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur. Neurol. 37, 212-218 (1997
    • (1997) Eur. Neurol , vol.37 , pp. 212-218
    • Chen, R.S.1    Huang, C.C.2    Chu, N.S.3
  • 29
    • 0029072626 scopus 로고
    • Short-term dichloracetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders
    • De Stefano, N. et al. Short-term dichloracetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45, 1193-1198 (1995
    • (1995) Neurology , vol.45 , pp. 1193-1198
    • De Stefano, N.1
  • 30
    • 1942537035 scopus 로고    scopus 로고
    • Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism
    • Duncan, G. E., Perkins, L. A., Theriaque, D. W., Neiberger, R. E. & Stacpoole, P. W. Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism. J. Clin. Endocrinol. Metab. 89, 1733-1738 (2004
    • (2004) J. Clin. Endocrinol. Metab , vol.89 , pp. 1733-1738
    • Duncan, G.E.1    Perkins, L.A.2    Theriaque, D.W.3    Neiberger, R.E.4    Stacpoole, P.W.5
  • 31
    • 84855355930 scopus 로고    scopus 로고
    • Initial experience in the treatment of inherited mitochondrial disease with EPI 743
    • Enns, G. M. et al. Initial experience in the treatment of inherited mitochondrial disease with EPI 743. Mol. Genet. Metab. 105, 91-102 (2012
    • (2012) Mol. Genet. Metab , vol.105 , pp. 91-102
    • Enns, G.M.1
  • 32
    • 78149325680 scopus 로고    scopus 로고
    • A randomized trial of coenzyme Q10 in mitochondrial disorders
    • Glover, E. I. et al. A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve 42, 739-748 (2010
    • (2010) Muscle Nerve , vol.42 , pp. 739-748
    • Glover, E.I.1
  • 33
    • 0029948495 scopus 로고    scopus 로고
    • Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: Results of a 6 month therapy study with coenzyme Q
    • Gold, R. et al. Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: Results of a 6 month therapy study with coenzyme Q. Eur. Neurol. 36, 191-196 (1996
    • (1996) Eur. Neurol , vol.36 , pp. 191-196
    • Gold, R.1
  • 34
    • 33646202306 scopus 로고    scopus 로고
    • Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
    • Kaufmann, P. et al. Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial. Neurology 66, 324-330 (2006
    • (2006) Neurology , vol.66 , pp. 324-330
    • Kaufmann, P.1
  • 35
    • 0034642154 scopus 로고    scopus 로고
    • A placebo-controlled crossover trial of creatine in mitochondrial diseases
    • Klopstock, T. et al. A placebo-controlled crossover trial of creatine in mitochondrial diseases. Neurology 55, 1748-1751 (2000
    • (2000) Neurology , vol.55 , pp. 1748-1751
    • Klopstock, T.1
  • 36
    • 80052959702 scopus 로고    scopus 로고
    • A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy
    • Klopstock, T. et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 134, 2677-2686 (2011
    • (2011) Brain , vol.134 , pp. 2677-2686
    • Klopstock, T.1
  • 37
    • 0037066134 scopus 로고    scopus 로고
    • Effects of l arginine on the acute phase of strokes in three patients with MELAS
    • Koga, Y. et al. Effects of l arginine on the acute phase of strokes in three patients with MELAS. Neurology 58, 827-828 (2002
    • (2002) Neurology , vol.58 , pp. 827-828
    • Koga, Y.1
  • 38
    • 0037231131 scopus 로고    scopus 로고
    • Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies
    • Komura, K., Hobbiebrunken, E., Wilichowski, E. K. & Hanefeld, F. A. Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies. Pediatr. Neurol. 28, 53-58 (2003
    • (2003) Pediatr. Neurol , vol.28 , pp. 53-58
    • Komura, K.1    Hobbiebrunken, E.2    Wilichowski, E.K.3    Hanefeld, F.A.4
  • 39
    • 84867897915 scopus 로고    scopus 로고
    • EPI 743 reverses the progression of the pediatric mitochondrial disease-genetically defined Leigh Syndrome
    • Martinelli, D. et al. EPI 743 reverses the progression of the pediatric mitochondrial disease-genetically defined Leigh Syndrome. Mol. Genet. Metab. 107, 383-388 (2012
    • (2012) Mol. Genet. Metab , vol.107 , pp. 383-388
    • Martinelli, D.1
  • 40
    • 84975452084 scopus 로고    scopus 로고
    • Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?
    • Mashima, Y., Kigasawa, K., Wakakura, M & Oguchi, Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J. Neuroophthalmol. 20, 166-170 (2000
    • (2000) J. Neuroophthalmol , vol.20 , pp. 166-170
    • Mashima, Y.1    Kigasawa, K.2    Wakakura, M.3    Oguchi, Y.4
  • 41
    • 0027722281 scopus 로고
    • Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies
    • Mathews, P. M., Andermann, F., Silver, K., Karpati, G. & Arnold, D. L. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43, 2484-2490 (1993
    • (1993) Neurology , vol.43 , pp. 2484-2490
    • Mathews, P.M.1    Andermann, F.2    Silver, K.3    Karpati, G.4    Arnold, D.L.5
  • 42
    • 4444228301 scopus 로고    scopus 로고
    • Dichloroacetate treatment for mitochondrial cytopathy: Long-term effects in MELAS
    • Mori, M., Yamagata, T., Goto, T., Saito, S. & Momoi, M. Y. Dichloroacetate treatment for mitochondrial cytopathy: Long-term effects in MELAS. Brain Dev. 26, 453-458 (2004
    • (2004) Brain Dev , vol.26 , pp. 453-458
    • Mori, M.1    Yamagata, T.2    Goto, T.3    Saito, S.4    Momoi, M.Y.5
  • 43
    • 58849137540 scopus 로고    scopus 로고
    • Multi-center trial on the early effects of silodosin on lower urinary tract symptoms associated with benign prostatic hyperplasia [Japanese]
    • Ogawa, T. et al. Multi-center trial on the early effects of silodosin on lower urinary tract symptoms associated with benign prostatic hyperplasia [Japanese]. Hinyokika Kiyo 54, 757-764 (2008
    • (2008) Hinyokika Kiyo , vol.54 , pp. 757-764
    • Ogawa, T.1
  • 44
    • 4344575973 scopus 로고    scopus 로고
    • Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases
    • Panetta, J., Smith, L. J. & Boneh, A. Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases. J. Inherit. Metab. Dis. 27, 487-498 (2004
    • (2004) J. Inherit. Metab. Dis , vol.27 , pp. 487-498
    • Panetta, J.1    Smith, L.J.2    Boneh, A.3
  • 45
    • 0037159183 scopus 로고    scopus 로고
    • Ubiquinone and nicotinamide treatment of patients with the 3243A ->G mtDNA mutation
    • Remes, A. M. et al. Ubiquinone and nicotinamide treatment of patients with the 3243A ->G mtDNA mutation. Neurology 59, 1275-1277 (2002
    • (2002) Neurology , vol.59 , pp. 1275-1277
    • Remes, A.M.1
  • 46
    • 33847000236 scopus 로고    scopus 로고
    • Beneficial effects of creatine CoQ10, and lipoic acid in mitochondrial disorders
    • Rodriguez, M. C. et al. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 35, 235-242 (2007
    • (2007) Muscle Nerve , vol.35 , pp. 235-242
    • Rodriguez, M.C.1
  • 47
    • 84858599179 scopus 로고    scopus 로고
    • Effect of EPI 743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy
    • Sadun, A. A. et al. Effect of EPI 743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch. Neurol. 69, 331-338 (2012
    • (2012) Arch. Neurol , vol.69 , pp. 331-338
    • Sadun, A.A.1
  • 48
    • 40849131523 scopus 로고    scopus 로고
    • Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate
    • Stacpoole, P. W. et al. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics 121, e1223-e1228 (2008
    • (2008) Pediatrics , vol.121
    • Stacpoole, P.W.1
  • 49
    • 33646830260 scopus 로고    scopus 로고
    • Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children
    • Stacpoole, P. W. et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 117, 1519-1531 (2006
    • (2006) Pediatrics , vol.117 , pp. 1519-1531
    • Stacpoole, P.W.1
  • 50
    • 0031596402 scopus 로고    scopus 로고
    • The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation
    • Suzuki, S. et al. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 41, 584-588 (1998
    • (1998) Diabetologia , vol.41 , pp. 584-588
    • Suzuki, S.1
  • 51
    • 33845285545 scopus 로고    scopus 로고
    • Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions
    • Taivassalo, T. et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 129, 3391-3401 (2006
    • (2006) Brain , vol.129 , pp. 3391-3401
    • Taivassalo, T.1
  • 52
    • 0030731246 scopus 로고    scopus 로고
    • Randomised control trial of creatine monohydrate in patients with mitochondrial cytopathies
    • Tarnopolsky, M. A., Roy, B. D. & MacDonald, J. R. Randomised control trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 20, 1502-1509 (1997
    • (1997) Muscle Nerve , vol.20 , pp. 1502-1509
    • Tarnopolsky, M.A.1    Roy, B.D.2    MacDonald, J.R.3
  • 53
    • 0029914622 scopus 로고    scopus 로고
    • Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control
    • Jadad, A. R. et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control. Clin. Trials 17, 1-12 (1996
    • (1996) Clin. Trials , vol.17 , pp. 1-12
    • Jadad, A.R.1
  • 54
    • 80051478879 scopus 로고    scopus 로고
    • Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study
    • Mazzone, E. et al. Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study. Neurology 77, 250-256 (2011
    • (2011) Neurology , vol.77 , pp. 250-256
    • Mazzone, E.1
  • 55
    • 75849124774 scopus 로고    scopus 로고
    • US National Library Of Medicine gov [online]
    • US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00432744?term=NCT00432744&rank=1 (2013
    • (2013) Clinical Trials
  • 57
    • 34548606803 scopus 로고    scopus 로고
    • Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: A randomised, placebo-controlled trial
    • Di Prospero, N. A., Baker, A., Jeffries, N. & Fischbeck, K. H. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: A randomised, placebo-controlled trial. Lancet Neurol. 6, 878-886 (2007
    • (2007) Lancet Neurol , vol.6 , pp. 878-886
    • Di Prospero, N.A.1    Baker, A.2    Jeffries, N.3    Fischbeck, K.H.4
  • 58
    • 77955450939 scopus 로고    scopus 로고
    • A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia
    • Lynch, D. R., Perlman, S. L. & Meier, T. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. Arch. Neurol. 67, 941-947 (2010
    • (2010) Arch. Neurol , vol.67 , pp. 941-947
    • Lynch, D.R.1    Perlman, S.L.2    Meier, T.3
  • 59
    • 79952451186 scopus 로고    scopus 로고
    • Idebenone in Friedreich ataxia cardiomyopathy-results from a 6 month phase III study (IONIA
    • Lagedrost, S. J. et al. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6 month phase III study (IONIA). Am. Heart J. 161, 639.e1-645.e1 (2011
    • (2011) Am. Heart J. , vol.161
    • Lagedrost, S.J.1
  • 60
    • 84864039693 scopus 로고    scopus 로고
    • Antioxidants and other pharmacological treatments for Friedreich ataxia
    • Kearney, M., Orrell, R. W., Fahey, M. & Pandolfo, M. Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD007791. http://onlinelibrary.wiley.com/ doi/10.1002/14651858.CD007791.pub3/abstract.
    • Cochrane Database of Systematic Reviews
    • Kearney, M.1    Orrell, R.W.2    Fahey, M.3    Pandolfo, M.4
  • 61
    • 84876326795 scopus 로고    scopus 로고
    • CATENA® (idebenone)-voluntary withdrawal of CATENA® from the Canadian market [online]
    • CATENA® (idebenone) - voluntary withdrawal of CATENA® from the Canadian market. Health Canada [online]. http://healthycanadians.gc.ca/recall- alert-rappel-avis/hc-sc/2013/23509a-eng.php (2013
    • (2013) Health Canada
  • 62
    • 39649084919 scopus 로고    scopus 로고
    • The FDA critical path initiative and its influence on new drug development
    • Woodcock, J. & Woosley, R. The FDA critical path initiative and its influence on new drug development. Annu. Rev. Med. 59, 1-12 (2008
    • (2008) Annu. Rev. Med , vol.59 , pp. 1-12
    • Woodcock, J.1    Woosley, R.2
  • 63
    • 84880173824 scopus 로고    scopus 로고
    • Towards the harmonization of outcome measures in children with mitochondrial disorders
    • Koene, S. et al. Towards the harmonization of outcome measures in children with mitochondrial disorders. Dev. Med. Child. Neurol. http://dx.doi.org/10.1111/dmcn.12119.
    • Dev. Med. Child. Neurol
    • Koene, S.1
  • 64
    • 84873316509 scopus 로고    scopus 로고
    • Developing outcome measures for pediatric mitochondrial disorders: Which complaints and limitations are most burdensome to patients and their parents?
    • Koene, S et al. Developing outcome measures for pediatric mitochondrial disorders: Which complaints and limitations are most burdensome to patients and their parents? Mitochondrion 13, 15-24 (2013
    • (2013) Mitochondrion , vol.13 , pp. 15-24
    • Koene, S.1
  • 65
    • 33845288002 scopus 로고    scopus 로고
    • Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy
    • Jeppesen, T. D. et al. Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Brain 129, 3402-3412 (2006
    • (2006) Brain , vol.129 , pp. 3402-3412
    • Jeppesen, T.D.1
  • 71
    • 0029135075 scopus 로고
    • CPEO and carnitine deficiency overlapping in MELAS syndrome
    • Hsu, C. C. et al. CPEO and carnitine deficiency overlapping in MELAS syndrome. Acta Neurol. Scand. 92, 252-255 (1995
    • (1995) Acta Neurol. Scand , vol.92 , pp. 252-255
    • Hsu, C.C.1
  • 72
    • 0030853576 scopus 로고    scopus 로고
    • Metabolic interventions against complex I deficiency in MELAS syndrome
    • Majamaa, K., Rusanen, H., Remes, A. & Hassinen, I. E. Metabolic interventions against complex I deficiency in MELAS syndrome. Mol. Cell Biochem. 174, 291-296 (1997
    • (1997) Mol. Cell Biochem , vol.174 , pp. 291-296
    • Majamaa, K.1    Rusanen, H.2    Remes, A.3    Hassinen, I.E.4
  • 73
    • 20144387513 scopus 로고    scopus 로고
    • Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: A placebo-controlled, double-blind 31P-MRS crossover study
    • Kornblum, C. et al. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: A placebo-controlled, double-blind 31P-MRS crossover study. Eur. J. Neurol. 12, 300-309 (2005
    • (2005) Eur. J. Neurol , vol.12 , pp. 300-309
    • Kornblum, C.1
  • 74
    • 0029164362 scopus 로고
    • Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy
    • Barbiroli, B. et al. Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy. J. Neurol. 242, 472-477 (1995
    • (1995) J. Neurol , vol.242 , pp. 472-477
    • Barbiroli, B.1
  • 75
    • 0001179515 scopus 로고    scopus 로고
    • Aerobic training benefits patients with mitochondrial myopathies more than other chronic myopathies
    • Taivassalo, T. et al. Aerobic training benefits patients with mitochondrial myopathies more than other chronic myopathies. Neurology 48, A214 (1997
    • (1997) Neurology , vol.48
    • Taivassalo, T.1
  • 76
    • 0029658242 scopus 로고    scopus 로고
    • A novel heteroplasmic tRNAleu(UUR) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in muscle and suggests an approach to therapy
    • Fu, K. et al. A novel heteroplasmic tRNAleu(UUR) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in muscle and suggests an approach to therapy. Hum. Mol. Genet. 5, 1835-1840 (1996
    • (1996) Hum. Mol. Genet , vol.5 , pp. 1835-1840
    • Fu, K.1
  • 77
    • 0030926104 scopus 로고    scopus 로고
    • Correction of a mitochondrial DNA defect in human skeletal muscle
    • Clark, K. et al. Correction of a mitochondrial DNA defect in human skeletal muscle. Nat. Genet. 16, 222-224 (1997
    • (1997) Nat. Genet , vol.16 , pp. 222-224
    • Clark, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.